申请人:Riken
公开号:EP3564232A1
公开(公告)日:2019-11-06
The present invention relates to novel and excellent small-molecule-compounds that specifically antagonize BMP signal pathways, and these compounds can be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus can be used to treat diseases or pathological symptoms related to BMP signal pathway including inflammation, cardiovascular diseases, hematopoietic diseases, cancer, osteodystrophia, or the like, particularly, fibrodysplasia ossificans progressiva, and the present invention relates to provision of a pharmaceutical and pharmacological agent used for specifically antagonizing the BMP signal pathways and acting on the BMP signal pathways in the prevention and treatment or experimental application since the compounds can be beneficial for regulating cell differentiation and/or cell proliferation.
本发明涉及特异性拮抗BMP信号通路的新型优良小分子化合物,这些化合物可用于调节细胞生长、分化、增殖和凋亡,从而可用于治疗与BMP信号通路相关的疾病或病理症状,包括炎症、心血管疾病、造血疾病、癌症、骨营养不良症、本发明涉及提供一种用于特异性拮抗 BMP 信号通路并作用于 BMP 信号通路的药物和药理制剂,以预防和治疗或实验应用,因为该化合物可有益于调节细胞分化和/或细胞增殖。